menu

Advances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Advances in HR-MDS: Updates in Diagnosis, Risk Assessment, and Current Standard of Care Challenges

3 chapters
Play All
Details
Chapters
Recommended

Overview

Chapter 1
ReachMD Healthcare Image
RestartResume

Epidemiology, Pathogenesis, & Diagnosis

  • Sponsored by

  • Overview

    It wasn’t until 2001, the same year that the original World Health Organization’s classification came out, that myelodysplastic syndrome (MDS) became a reportable condition to cancer registries, as before this it was considered precancerous rather than neoplastic. To learn more, join Dr. Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center. 

     

    ABBV-US-01481-MC
    AbbVie Inc. Version 1.0 Approved February 2024
Schedule24 Apr 2024